Case Report
Volume: 2 | Issue: 2 | Published: Dec 05, 2019 | Pages: 143 - 146 | DOI: 10.24911/JBCGenetics/183-1566823566
Congenital muscular dystrophy a case study with a mutation in the POMT1 gene
Authors:
Muhsin Elmas
, Basak Gogus
, Dilek Cavusoglu
, Ayhan Pektas
, Mustafa Solak
Article Info
Authors
Muhsin Elmas
Afyonkarahisar Health Sciences University, Faculty of Medicine, Medical Genetics Department Afyonkarahisar, Turkey
Basak Gogus
Afyonkarahisar Health Sciences University, Faculty of Medicine, Medical Genetics Department Afyonkarahisar, Turkey
Dilek Cavusoglu
Afyonkarahisar Health Sciences University, Faculty of Medicine, Pediatric Department, Afyonkarahisar, Turkey
Ayhan Pektas
Afyonkarahisar Health Sciences University, Faculty of Medicine, Pediatric Department, Afyonkarahisar, Turkey
Mustafa Solak
Afyonkarahisar Health Sciences University, Faculty of Medicine, Medical Genetics Department Afyonkarahisar, Turkey
Publication History
Received: August 26, 2019
Revised: September 19, 2019
Accepted: October 07, 2019
Published: December 05, 2019
Abstract
Background: The congenital muscular dystrophies (CMD) are a group of heterogeneous diseases, manifested with a wide variety of clinical findings. Dystroglycanopathy is regarded as a subgroup among the CMD group of diseases. POMT1 mutations that cause alpha-dystroglycan hypoglycolization are reported to cause CMD diseases with autosomal recessive inheritance pattern. Case Presentation: A 14-year-old girl patient was referred with classical symptoms for CMDs. Whole exome sequencing (WES) analysis revealed a mutation in the POMT1 gene after the differential diagnosis of the patient. A homozygous mutation detected in the patient diagnosed muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1 (OMIM 613155). Conclusion: Different mutations in the POMT1 gene have been found to cause three different types of diseases (CMDs). The differential diagnosis for these diseases clinically remains difficult, as a result, detailed clinical evaluation of patients becomes mandatory. Also, a multidisciplinary and collaborative approach involving complete clinical information and anamnesis is essential for the interpretation of genetic test results for such complex disorders.
Keywords: Muscular dystrophies, consanguinity, developmental disabilities